Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models.

Osteoarthritis (OA), one of the most common skeletal disorders characterized by cartilage degradation and osteophyte formation in joints, is induced by accumulated mechanical stress; however, little is known about the underlying molecular mechanism. Several experimental OA models in mice by producing instability in the knee joints have been developed to apply approaches from mouse genetics. Although proteinases like matrix metalloproteinases and aggrecanases have now been proven to be the principal initiators of OA progression, clinical trials of proteinase inhibitors have not been successful for the treatment, turning the interest of researchers to the upstream signals of proteinase induction. These signals include undegraded and fragmented matrix proteins like type II collagen or fibronection that affects chondrocytes through distinct receptors. Another signal is pro-inflammatory factors that are produced by chondrocytes and synovial cells; however, recent studies that used mouse OA models in knockout mice did not support that these factors have a role in the central contribution to OA development. Our mouse genetic approaches found that the induction of a transcriptional activator Runx2 in chondrocytes under mechanical stress contributes to the pathogenesis of OA through chondrocyte hypertrophy. In addition, chondrocyte apoptosis has recently been identified as being involved in OA progression. We hereby propose that these endochondral ossification signals may be important for the OA progression, suggesting that the related molecules can clinically be therapeutic targets of this disease.

[1]  T. Wakayama,et al.  Skeletal malformations caused by the Dh (Dominant hemimelia) gene in mice. , 1996, Experimental animals.

[2]  Kozo Nakamura,et al.  Carminerin contributes to chondrocyte calcification during endochondral ossification , 2006, Nature Medicine.

[3]  Kozo Nakamura,et al.  Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. , 2008, Arthritis and rheumatism.

[4]  S. Glasson,et al.  The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. , 2007, Osteoarthritis and cartilage.

[5]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[6]  G. Nuki,et al.  Experimentally-induced osteoarthritis in the dog. , 1973, Annals of the rheumatic diseases.

[7]  C. Little,et al.  Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair. , 2007, The Journal of clinical investigation.

[8]  Kozo Nakamura,et al.  Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. , 2006, Arthritis and rheumatism.

[9]  W. Richter,et al.  Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading , 2004, Arthritis research & therapy.

[10]  Kozo Nakamura,et al.  Cystatin 10, a Novel Chondrocyte-specific Protein, May Promote the Last Steps of the Chondrocyte Differentiation Pathway* , 2003, Journal of Biological Chemistry.

[11]  D. D’Lima,et al.  Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. , 2006, Arthritis and rheumatism.

[12]  K. Nakamura,et al.  Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. , 1999, Rheumatology.

[13]  Y. Yoo,et al.  TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. , 2004, Arthritis and rheumatism.

[14]  Y. Figenschau,et al.  Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro. , 2002, Biochemical and biophysical research communications.

[15]  M. Chung,et al.  Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis. , 2002, Arthritis and rheumatism.

[16]  C. Brinckerhoff,et al.  Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors , 2001, Arthritis Research & Therapy.

[17]  R. Mason,et al.  Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. , 2003, Arthritis and rheumatism.

[18]  J. Jordan,et al.  Epidemiology of osteoarthritis. , 2010, Clinics in geriatric medicine.

[19]  B. Olsen,et al.  Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. , 2007, Arthritis and rheumatism.

[20]  C. Brinckerhoff,et al.  Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. , 2007, Current drug targets.

[21]  S. Miyamoto,et al.  Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis , 2004, Arthritis research & therapy.

[22]  T. Muneta,et al.  Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. , 2007, Arthritis and rheumatism.

[23]  F. Berenbaum,et al.  Cyclooxygenase activity in chondrocytes from osteoarthritic and healthy cartilage. , 1999, Revue du rhumatisme.

[24]  E. Vignon,et al.  Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. , 2002, Biorheology.

[25]  L. Duong,et al.  The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. , 2004, Arthritis and rheumatism.

[26]  A. Fourie,et al.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro , 2005, Nature.

[27]  H. Inoue,et al.  Epidemiology of Osteoarthritis of the Knee , 1995 .

[28]  B. Olsen,et al.  Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease. , 2007, Osteoarthritis and cartilage.

[29]  N. Boos,et al.  Immunohistochemical Analysis of Type X-Collagen Expression in Osteoarthritis of the Hip Joint , 2000 .

[30]  E. Vignon,et al.  Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[31]  B. Olsen,et al.  Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦ , 2005, Journal of Biological Chemistry.

[32]  D. D’Lima,et al.  Cell death in cartilage. , 2004, Osteoarthritis and cartilage.

[33]  N. Kanatani,et al.  Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.

[34]  Kozo Nakamura,et al.  Osteoarthritis development in novel experimental mouse models induced by knee joint instability. , 2005, Osteoarthritis and cartilage.

[35]  J. Matyas,et al.  The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. , 1999, Arthritis and rheumatism.

[36]  Yusuke Nakamura,et al.  Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine , 1998, Nature Genetics.

[37]  S. Glasson In vivo osteoarthritis target validation utilizing genetically-modified mice. , 2007, Current drug targets.

[38]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[39]  K. von der Mark,et al.  Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. , 1992, Arthritis and rheumatism.

[40]  C. López-Otín,et al.  Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation , 1999, Molecular and Cellular Biology.